Wilson & Melville Medical Services Limited 14404597 false 2024-11-01 2025-10-31 2025-10-31 The principal activity of the company is that of specialist medical activities. Digita Accounts Production Advanced 6.30.9574.0 true 14404597 2024-11-01 2025-10-31 14404597 2025-10-31 14404597 bus:OrdinaryShareClass1 2025-10-31 14404597 bus:OrdinaryShareClass2 2025-10-31 14404597 bus:OrdinaryShareClass3 2025-10-31 14404597 core:RetainedEarningsAccumulatedLosses 2025-10-31 14404597 core:ShareCapital 2025-10-31 14404597 core:CurrentFinancialInstruments core:WithinOneYear 2025-10-31 14404597 core:FurnitureFittingsToolsEquipment 2025-10-31 14404597 bus:SmallEntities 2024-11-01 2025-10-31 14404597 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 14404597 bus:FilletedAccounts 2024-11-01 2025-10-31 14404597 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 14404597 bus:RegisteredOffice 2024-11-01 2025-10-31 14404597 bus:Director1 2024-11-01 2025-10-31 14404597 bus:Director2 2024-11-01 2025-10-31 14404597 bus:OrdinaryShareClass1 2024-11-01 2025-10-31 14404597 bus:OrdinaryShareClass2 2024-11-01 2025-10-31 14404597 bus:OrdinaryShareClass3 2024-11-01 2025-10-31 14404597 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 14404597 bus:Agent1 2024-11-01 2025-10-31 14404597 core:FurnitureFittingsToolsEquipment 2024-11-01 2025-10-31 14404597 core:OfficeEquipment 2024-11-01 2025-10-31 14404597 countries:England 2024-11-01 2025-10-31 14404597 2024-10-31 14404597 core:FurnitureFittingsToolsEquipment 2024-10-31 14404597 2023-11-01 2024-10-31 14404597 2024-10-31 14404597 bus:OrdinaryShareClass1 2024-10-31 14404597 bus:OrdinaryShareClass2 2024-10-31 14404597 bus:OrdinaryShareClass3 2024-10-31 14404597 core:RetainedEarningsAccumulatedLosses 2024-10-31 14404597 core:ShareCapital 2024-10-31 14404597 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 14404597 core:FurnitureFittingsToolsEquipment 2024-10-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 14404597

Wilson & Melville Medical Services Limited
Unaudited Filleted Financial Statements
for the Year Ended 31 October 2025

Wilson & Melville Medical Services Limited

Contents

Company Information | 1
Accountants' Report | 2
Balance Sheet | 3
Notes to the Unaudited Financial Statements | 4 to 7

Wilson & Melville Medical Services Limited

Company Information

Directors | Dr B E Melville Dr D Melville

Registered office | Wellesley House 204 London Road Waterlooville Hampshire England PO7 7AN

Accountants | MMO Limited Wellesley House 204 London Road Waterlooville Hampshire PO7 7AN

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Wilson & Melville Medical Services Limited
for the Year Ended 31 October 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Wilson & Melville Medical Services Limited for the year ended 31 October 2025 as set out on pages 3 to 7 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of Wilson & Melville Medical Services Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Wilson & Melville Medical Services Limited and state those matters that we have agreed to state to the Board of Directors of Wilson & Melville Medical Services Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Wilson & Melville Medical Services Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Wilson & Melville Medical Services Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Wilson & Melville Medical Services Limited. You consider that Wilson & Melville Medical Services Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Wilson & Melville Medical Services Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................
MMO Limited
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

6 July 2026

Wilson & Melville Medical Services Limited

(Registration number: 14404597)
Balance Sheet as at 31 October 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 4 | 3,141 | 3,589
Current assets |  |  |
Cash at bank and in hand |  | 93,439 | 66,557
Creditors: Amounts falling due within one year | 5 | (28,772) | (26,541)
Net current assets |  | 64,667 | 40,016
Total assets less current liabilities |  | 67,808 | 43,605
Provisions for liabilities |  | (597) | (682)
Net assets |  | 67,211 | 42,923
Capital and reserves |  |  |
Called up share capital | 6 | 120 | 120
Retained earnings |  | 67,091 | 42,803
Shareholders' funds |  | 67,211 | 42,923

For the financial year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 5 July 2026 and signed on its behalf by:

......................................... Dr B E Melville Director

Wilson & Melville Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

1 | General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN
England

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

All figures are presented in British Sterling, which is the functional currency of the company, and are rounded to the nearest £1.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

Wilson & Melville Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.
Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Office equipment | 25% - written down value

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Wilson & Melville Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2024 - 2).

4 | Tangible assets

| Furniture, fittings and equipment £ | Total £
Cost or valuation
At 1 November 2024 | 3,757 | 3,757
Additions | 599 | 599
At 31 October 2025 | 4,356 | 4,356
Depreciation
At 1 November 2024 | 168 | 168
Charge for the year | 1,047 | 1,047
At 31 October 2025 | 1,215 | 1,215
Carrying amount
At 31 October 2025 | 3,141 | 3,141
At 31 October 2024 | 3,589 | 3,589

Wilson & Melville Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

5 | Creditors

Creditors: amounts falling due within one year

| 2025 £ | 2024 £
Due within one year |  |
Taxation and social security | 5,994 | 4,793
Accruals and deferred income | 1,500 | 1,500
Other creditors | 21,278 | 20,248
| 28,772 | 26,541

6 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Ordinary Shares of £1 each | 100 | 100 | 100 | 100
Ordinary A Shares of £1 each | 10 | 10 | 10 | 10
Ordinary B Shares of £1 each | 10 | 10 | 10 | 10
| 120 | 120 | 120 | 120